Perrigo Company plc $PRGO Stock Position Increased by West Tower Group LLC

West Tower Group LLC increased its position in shares of Perrigo Company plc (NYSE:PRGO) by 45.1% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 352,522 shares of the company’s stock after purchasing an additional 109,567 shares during the quarter. Perrigo accounts for approximately 11.8% of West Tower Group LLC’s investment portfolio, making the stock its 2nd largest holding. West Tower Group LLC’s holdings in Perrigo were worth $3,786,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of PRGO. Price T Rowe Associates Inc. MD lifted its stake in Perrigo by 3.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 17,574,227 shares of the company’s stock valued at $244,634,000 after acquiring an additional 653,925 shares during the period. Vanguard Group Inc. boosted its holdings in Perrigo by 7.9% in the fourth quarter. Vanguard Group Inc. now owns 14,983,369 shares of the company’s stock valued at $208,568,000 after purchasing an additional 1,101,154 shares during the last quarter. Fuller & Thaler Asset Management Inc. grew its position in Perrigo by 291.9% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 7,824,759 shares of the company’s stock worth $108,921,000 after purchasing an additional 5,828,076 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of Perrigo by 2.4% during the 3rd quarter. Dimensional Fund Advisors LP now owns 7,695,238 shares of the company’s stock valued at $171,367,000 after buying an additional 181,828 shares during the last quarter. Finally, State Street Corp raised its stake in shares of Perrigo by 9.5% during the 2nd quarter. State Street Corp now owns 7,340,323 shares of the company’s stock valued at $196,134,000 after buying an additional 637,678 shares during the last quarter. Institutional investors and hedge funds own 95.91% of the company’s stock.

Perrigo Price Performance

NYSE:PRGO opened at $11.20 on Wednesday. The stock has a market capitalization of $1.55 billion, a PE ratio of -0.86, a price-to-earnings-growth ratio of 1.32 and a beta of 0.51. Perrigo Company plc has a 52 week low of $9.23 and a 52 week high of $28.43. The company has a quick ratio of 1.59, a current ratio of 2.72 and a debt-to-equity ratio of 1.45. The stock’s 50-day moving average price is $10.86 and its 200-day moving average price is $12.08.

Perrigo (NYSE:PRGO) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.39 by $0.04. The company had revenue of $841.80 million for the quarter, compared to analyst estimates of $1.04 billion. Perrigo had a positive return on equity of 9.96% and a negative net margin of 43.50%.Perrigo’s quarterly revenue was down 7.2% compared to the same quarter last year. During the same period last year, the company earned $0.60 earnings per share. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, equities analysts expect that Perrigo Company plc will post 2.11 EPS for the current fiscal year.

Perrigo Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Friday, May 29th were issued a $0.29 dividend. This represents a $1.16 annualized dividend and a yield of 10.4%. The ex-dividend date of this dividend was Friday, May 29th. Perrigo’s payout ratio is presently -8.85%.

Wall Street Analyst Weigh In

A number of analysts have recently commented on PRGO shares. Zacks Research upgraded Perrigo from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Weiss Ratings upgraded Perrigo from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, June 15th. One equities research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $19.33.

Perrigo Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.